The heterogeneous nature of the mechanisms underlying neuropathic pain complicates the selection of appropriate treatments for individual patients. Although systematic reviews have outlined the ...

Researchers at Weill Cornell Medicine and the Burke Neurological Institute have made an exciting discovery—a new drug that ...

Averitas Pharma, the US subsidiary of Grünenthal, has completed patient recruitment for the Phase III AV001 clinical study, ...

At present, the impact of the pharmacogenetics on the response to treatment in neuropathic pain is poorly known, but several polymorphisms, among them the cytochrome P450 (CYP)2D6, may intervene.

Find out about the groundbreaking MDMA clinical trial for chronic nerve pain. Discover how this study aims to test the impact of MDMA compared to a placebo.

Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...

If you’re new to CBD, it’s best to start with ... needed before experts can conclude CBD is an effective treatment for nerve-related pain. The CBD world is filled with a lot of claims and ...

秋风送爽，丹桂飘香。近日（9月19日-22日），由中华医学会、中华医学会神经病学分会主办，河南省医学会承办的“中华医学会第二十七次神经病学学术会议”在美丽的郑州顺利召开。国内外知名专家学者齐聚，共享学术饕餮盛宴。神经病理性疼痛（NP）指由躯体感觉系统 ...

European researchers have mapped the most comprehensive phenotyping of neuropathic pain and identified ... improving patient quality of life and treatment outcomes. New research describes for ...

low-dose antiviral treatment reduces the risk for potentially vision-damaging bouts of inflammation and infection, as well as pain, which occur when shingles affects the eye, according to new ...

Recent evidence suggests that acupuncture can help relieve the pain caused by sciatica, a common condition in which the ...